Putney Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Sell
1,357
-9
-0.7% -$9.2K 1.47% 16
2026
Q1
$1.26M Sell
1,366
-31
-2% -$31.4K 1.27% 18
2025
Q4
$1.5M Sell
1,397
-21
-1% -$20.1K 1.4% 16
2025
Q3
$1.08M Hold
1,418
1.07% 20
2025
Q2
$1.11M Sell
1,418
-77
-5% -$59.8K 1.12% 21
2025
Q1
$1.23M Sell
1,495
-272
-15% -$226K 1.3% 16
2024
Q4
$1.36M Buy
+1,767
New +$1.46M 1.22% 18

Other funds holding LLY

Putney Financial Group's LLY Position: Q2 2026 in Review

Putney Financial Group reduced its Eli Lilly (LLY) stake by 0.66% in Q2 2026, selling an estimated $9.2K and leaving 1,357 shares worth $1.63M. The position accounts for 1.47% of the portfolio, ranked #16.

Putney Financial Group first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Putney Financial Group held 1,357 shares of Eli Lilly worth $1.63M as of Q2 2026.
  • Putney Financial Group sold 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 1.47% of Putney Financial Group's portfolio in Q2 2026, its #16 holding.
  • Putney Financial Group first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Putney Financial Group's 13F filing for Q2 2026, filed 21 Jul 2026.